Literature DB >> 2822111

Rb+ occlusion in renal (Na+ + K+)-ATPase characterized with a simple manual assay.

M Shani1, R Goldschleger, S J Karlish.   

Abstract

This paper describes properties of a simple manual assay for Rb+ occlusion on renal (Na+ + K+)-ATPase. Rb+ occlusion is measured by applying the enzyme plus Rb+ (86Rb) mixture to a Dowex-50 cation exchange column at 0 degree C, and eluting the enzyme with occluded Rb+ using an ice-cold sucrose solution. The enzyme-Rb+ complex is quite stable at 0 degree C. This method is useful for measuring Rb+ occlusion under equilibrium binding conditions and slow rates of dissociation of the enzyme-Rb+ complex. The stoichiometry of Rb+ occluded per phosphorylation site is 2. Rb+ saturation curves are strictly hyperbolic, suggesting that the two Rb+ sites have very different affinities, one in the micromolar range and one in the tens of millimolar range. ATP shifts the Rb+ saturation curves to the right (control K0.5 100-200 microM; plus ATP, K0.5 0.8-1.4 mM, in a 100 mM Tris-HCl medium, pH 7.0) and reduces the maximal level occluded (control approx. 4 nmol/mg; plus ATP approx. 3 nmol/mg protein). Thus, as expected, ATP shifts the E(1)2Rb+-E2(2Rb+)occ equilibrium towards E1. Sodium ions at concentrations of up to 30 mM compete with the rubidium ions, KNa = 1.86 mM in the Tris-HCl medium. Na+ at higher concentrations (30-100 mM) has an added non-competitive antagonistic effect. At room temperature, Rb+ dissociates slowly from the enzyme, kobs = 0.08 s-1, in the presence of either Rb+ (20 mM) or Na, (100 mM). As expected, dissociation is greatly accelerated by ATP, the rate being to fast to be measured by this technique. (Na+ + K+)-ATPase proteolyzed selectively by chymotrypsin in a Na+ medium, occludes Rb+. For control and proteolyzed (Na+ + K+)-ATPase the Rb+ saturation curves are similar and the rates of dissociation of the enzyme-Rb+ complex are identical. The chymotryptic split appears to disrupt antagonistic interactions between cation and ATP binding domains, while the E1-E2 conformational transition of the unphosphorylated protein probably remains.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822111     DOI: 10.1016/0005-2736(87)90081-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Chemical modification of Glu-953 of the alpha chain of Na+,K(+)-ATPase associated with inactivation of cation occlusion.

Authors:  R Goldshleger; D M Tal; J Moorman; W D Stein; S J Karlish
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

2.  Identification of electric-field-dependent steps in the Na(+),K(+)-pump cycle.

Authors:  Laura J Mares; Alvaro Garcia; Helge H Rasmussen; Flemming Cornelius; Yasser A Mahmmoud; Joshua R Berlin; Bogdan Lev; Toby W Allen; Ronald J Clarke
Journal:  Biophys J       Date:  2014-09-16       Impact factor: 4.033

3.  Investigation of ion binding to the cytoplasmic binding sites of the Na,K-pump.

Authors:  S Schulz; H J Apell
Journal:  Eur Biophys J       Date:  1995       Impact factor: 1.733

4.  The amino-terminal segment of the catalytic subunit of kidney Na,K-ATPase regulates the potassium deocclusion pathway of the reaction cycle.

Authors:  W Wierzbicki; R Blostein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

5.  Electrogenic and electroneutral transport modes of renal Na/K ATPase reconstituted into proteoliposomes.

Authors:  R Goldshleger; Y Shahak; S J Karlish
Journal:  J Membr Biol       Date:  1990-02       Impact factor: 1.843

6.  A 19-kDa C-terminal tryptic fragment of the alpha chain of Na/K-ATPase is essential for occlusion and transport of cations.

Authors:  S J Karlish; R Goldshleger; W D Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Membrane disposition of the M5-M6 hairpin of Na+,K(+)-ATPase alpha subunit is ligand dependent.

Authors:  S Lutsenko; R Anderko; J H Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.